{
    "nct_id": "NCT03395210",
    "official_title": "An Adaptive, Open-Label, Dose-Finding, Phase 1/2 Study Investigating the Safety, Pharmacokinetics, and Clinical Activity of PRN1008, an Oral BTK Inhibitor, in Patients With Relapsed Immune Thrombocytopenia",
    "inclusion_criteria": "* Male or female patients, aged 18 to 80 years old\n* Immune-related ITP (both primary and secondary)\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Pregnant or lactating women\n* Current drug or alcohol abuse\n* History of solid organ transplant\n* Positive screening for HIV, hepatitis B, or hepatitis C",
    "miscellaneous_criteria": ""
}